These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15140202)

  • 1. Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism.
    Liu K; Paterson AJ; Zhang F; McAndrew J; Fukuchi K; Wyss JM; Peng L; Hu Y; Kudlow JE
    J Neurochem; 2004 May; 89(4):1044-55. PubMed ID: 15140202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells.
    Hanover JA; Lai Z; Lee G; Lubas WA; Sato SM
    Arch Biochem Biophys; 1999 Feb; 362(1):38-45. PubMed ID: 9917327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAc modification is an endogenous inhibitor of the proteasome.
    Zhang F; Su K; Yang X; Bowe DB; Paterson AJ; Kudlow JE
    Cell; 2003 Dec; 115(6):715-25. PubMed ID: 14675536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hexosamine signaling pathway: deciphering the "O-GlcNAc code".
    Love DC; Hanover JA
    Sci STKE; 2005 Nov; 2005(312):re13. PubMed ID: 16317114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.
    Forsythe ME; Love DC; Lazarus BD; Kim EJ; Prinz WA; Ashwell G; Krause MW; Hanover JA
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11952-7. PubMed ID: 16882729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
    Whelan SA; Hart GW
    Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of O-GlcNAc-modified proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats.
    Akimoto Y; Kawakami H; Yamamoto K; Munetomo E; Hida T; Hirano H
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3802-9. PubMed ID: 12939295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts.
    Gentiletti F; Mancini F; D'Angelo M; Sacchi A; Pontecorvi A; Jochemsen AG; Moretti F
    Oncogene; 2002 Jan; 21(6):867-77. PubMed ID: 11840332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of transcription factor function by O-GlcNAc modification.
    Ozcan S; Andrali SS; Cantrell JE
    Biochim Biophys Acta; 2010; 1799(5-6):353-64. PubMed ID: 20202486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation.
    Jin Y; Lee H; Zeng SX; Dai MS; Lu H
    EMBO J; 2003 Dec; 22(23):6365-77. PubMed ID: 14633995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.
    Akan I; Olivier-Van Stichelen S; Bond MR; Hanover JA
    J Neurochem; 2018 Jan; 144(1):7-34. PubMed ID: 29049853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does O-GlcNAc play a role in neurodegenerative diseases?
    Lefebvre T; Guinez C; Dehennaut V; Beseme-Dekeyser O; Morelle W; Michalski JC
    Expert Rev Proteomics; 2005 Apr; 2(2):265-75. PubMed ID: 15892570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development.
    Whisenhunt TR; Yang X; Bowe DB; Paterson AJ; Van Tine BA; Kudlow JE
    Glycobiology; 2006 Jun; 16(6):551-63. PubMed ID: 16505006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase.
    Wells L; Gao Y; Mahoney JA; Vosseller K; Chen C; Rosen A; Hart GW
    J Biol Chem; 2002 Jan; 277(3):1755-61. PubMed ID: 11788610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp90 regulates O-linked β-N-acetylglucosamine transferase: a novel mechanism of modulation of protein O-linked β-N-acetylglucosamine modification in endothelial cells.
    Zhang F; Snead CM; Catravas JD
    Am J Physiol Cell Physiol; 2012 Jun; 302(12):C1786-96. PubMed ID: 22496241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation.
    Legube G; Linares LK; Lemercier C; Scheffner M; Khochbin S; Trouche D
    EMBO J; 2002 Apr; 21(7):1704-12. PubMed ID: 11927554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells.
    Gao Y; Parker GJ; Hart GW
    Arch Biochem Biophys; 2000 Nov; 383(2):296-302. PubMed ID: 11185566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of p53 stability by Mdm2.
    Kubbutat MH; Jones SN; Vousden KH
    Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The levels of MDM2 protein are decreased by a proteasome-mediated proteolysis prior to caspase-3-dependent pRb and PARP cleavages.
    Cho JW; Park JC; Lee JC; Kwon TK; Park JW; Baek WK; Suh SI; Suh MH
    J Korean Med Sci; 2001 Apr; 16(2):135-9. PubMed ID: 11306736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.